Webex playback does not work on Microsoft Edge Browser. Please use an alternate browser such as Chrome or Firefox to view this recording.
This FluFIT/iFOBT three-part series is presented to you by a partnership of the American Cancer Society, Great Plains Quality Innovation Network, Great Plains Tribal Chairmans Health Board, National Colorectal Cancer Roundtable, Community Healthcare Association of the Dakotas, Kansas Cancer Partnership, North Dakota Department of Health, South Dakota Cancer Coalition and South Dakota Department of Health.
- Explain the value of FluFIT/iFOBT as an evidence-based intervention to increase access to colorectal cancer screening
- Understand the key planning steps of a quality FluFIT/iFOBT program
- Identify protocols to determine FluFIT/iFOBT patient eligibility
- Describe the FluFIT.org program materials available to support successful implementation
Michael B. Potter, MD
National Colorectal Cancer Roundtable
Michael B. Potter, MD is a graduate of Harvard College and Harvard Medical School and completed his training in Family Medicine at San Francisco General Hospital. He is Professor of Clinical Family and Community Medicine at the University of California, San Francisco and a member of the Helen Diller Comprehensive Cancer Center at UCSF. He sees patients and teaches medical students at UCSF Medical School and at San Francisco General Hospital. Dr. Potter is Director of the San Francisco Bay Area Collaborative Research Network (SF Bay CRN), a primary care practice-based research partnership between community-based clinicians, practices, and UCSF. Dr. Potter’s research focuses on innovative and practical approaches to promote cancer screening in diverse healthcare settings, especially in communities where access to cancer screening has traditionally been limited and where disparities in cancer screening rates persist. Dr. Potter is an individual member of the Roundtable and has served on several of its subcommittees before joining the Roundtable Steering Committee in 2008. He believes that the Roundtable has been an important source of support to increase public awareness of and access to high quality colorectal cancer screening nationally.